DE254530C - - Google Patents
Info
- Publication number
- DE254530C DE254530C DENDAT254530D DE254530DA DE254530C DE 254530 C DE254530 C DE 254530C DE NDAT254530 D DENDAT254530 D DE NDAT254530D DE 254530D A DE254530D A DE 254530DA DE 254530 C DE254530 C DE 254530C
- Authority
- DE
- Germany
- Prior art keywords
- cholic acid
- strontium
- solution
- preparation
- cholic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims description 16
- 239000004380 Cholic acid Substances 0.000 claims description 16
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 16
- 229960002471 cholic acid Drugs 0.000 claims description 16
- 235000019416 cholic acid Nutrition 0.000 claims description 16
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims description 16
- 229910052712 strontium Inorganic materials 0.000 claims description 11
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 11
- UUCCCPNEFXQJEL-UHFFFAOYSA-L strontium dihydroxide Chemical compound [OH-].[OH-].[Sr+2] UUCCCPNEFXQJEL-UHFFFAOYSA-L 0.000 claims description 5
- 229910001866 strontium hydroxide Inorganic materials 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 208000001130 gallstones Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical compound O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE254530C true DE254530C (en:Method) |
Family
ID=512712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT254530D Active DE254530C (en:Method) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE254530C (en:Method) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0092073A1 (en) * | 1982-04-15 | 1983-10-26 | SCHWARZ ITALIA S.p.A. | Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle |
| US5188995A (en) * | 1992-03-24 | 1993-02-23 | Phillips Petroleum Company | Reactivation and passivation of spent cracking catalysts |
| US6005155A (en) * | 1997-12-03 | 1999-12-21 | Exxon Chemicals Patents Inc. | Modification of molecular sieve catalyst for reduced methane production during conversion of oxygenates to olefins |
-
0
- DE DENDAT254530D patent/DE254530C/de active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0092073A1 (en) * | 1982-04-15 | 1983-10-26 | SCHWARZ ITALIA S.p.A. | Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle |
| US5188995A (en) * | 1992-03-24 | 1993-02-23 | Phillips Petroleum Company | Reactivation and passivation of spent cracking catalysts |
| US6005155A (en) * | 1997-12-03 | 1999-12-21 | Exxon Chemicals Patents Inc. | Modification of molecular sieve catalyst for reduced methane production during conversion of oxygenates to olefins |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE254530C (en:Method) | ||
| DE270258C (en:Method) | ||
| DE271894C (en:Method) | ||
| DE216267C (en:Method) | ||
| DE127649C (en:Method) | ||
| DE224979C (en:Method) | ||
| AT153216B (de) | Verfahren zur Darstellung komplexer Goldkeratinverbindungen. | |
| DE694100C (de) | Verfahren zur Gewinnung von Metallverbindungen wasrodukte | |
| AT117475B (de) | Verfahren zur Darstellung von Substitutionsprodukten des ß-Jodpyridins. | |
| DE249726C (en:Method) | ||
| DE293467C (en:Method) | ||
| DE270487C (en:Method) | ||
| DE267082C (en:Method) | ||
| DE909936C (de) | Verfahren zur Gewinnung von Wirkstoffen aus Blueten von Arnica montana | |
| DE514094C (de) | Verfahren zur Darstellung von Alkalisalzen aromatischer Sulfonhalogenamide | |
| DE248083C (en:Method) | ||
| DE706578C (de) | Verfahren zur Gewinnung von Praeparaten, die das Kreislaufhormon Kallikrein enthalten | |
| DE212389C (en:Method) | ||
| DE579820C (de) | Verfahren zur Gewinnung weiblicher Sexualhormone in kristallisierter Form | |
| DE157300C (en:Method) | ||
| DE701562C (de) | Verfahren zur Reinigung von Keimdruesenhormonen | |
| AT159318B (de) | Verfahren zur Darstellung leicht wasserlöslicher Verbindungen von Dialkylaminoalkyldiarylcarbinolen. | |
| DE68240C (de) | Verfahren zur Darstellung von p-Aethoxyantipyrin | |
| DE138845C (en:Method) | ||
| AT79825B (de) | Verfahren zur Herstellung eines neuen ChinindoppelVerfahren zur Herstellung eines neuen Chinindoppelsalzes. salzes. |